CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Current assets
Cash	$ 82,725	$ 26,766
Accounts receivable, net	6,823	5,231
Inventory, net	9,812	9,615
Other current assets	6,938	5,473
Total current assets	106,298	47,085
Property and equipment, net	2,079	2,335
Capitalized software, net	5,012	4,554
Operating lease right-of-use assets	240	356
Deferred tax asset	1,693
Total assets	115,322	54,330
Current liabilities
Accounts payable	8,314	4,349
Accrued expenses	16,268	6,011
Term loan, current	6,250	5,000
Deferred revenue, current	1,855	1,705
Operating lease liabilities, current	252	248
Total current liabilities	32,939	17,313
Term loan, net of current portion	114,810	31,963
Deferred revenue, net of current portion	853	802
Operating lease liabilities, net of current portion		127
Warrant liability	5,832
Earnout liability	32,200
Total liabilities	186,634	50,205
Commitments and contingencies (See Note 16)
Stockholders' Equity (Deficit)
Preferred stock, $0.0001 par value, 10,000,000 shares authorized; no shares issued or outstanding
Additional Paid in Capital	0	0
Retained earnings (Accumulated deficit)	(49,144)	4,165
Accumulated other comprehensive loss	(5)	(40)
biote Corp.'s stockholders' equity (deficit)	(49,143)	4,125
Noncontrolling interest	(22,169)
Total stockholders' equity (deficit)	(71,312)	4,125
Total liabilities and stockholders' equity (deficit)	115,322	54,330
Class A Common Stock
Stockholders' Equity (Deficit)
Common stock value	1
Class B Common Stock
Stockholders' Equity (Deficit)
Common stock value	0	$ 0
Class V Common Stock
Stockholders' Equity (Deficit)
Common stock value	$ 5